Your browser doesn't support javascript.
loading
Acute neuropsychological effects of MDMA and ethanol (co-)administration in healthy volunteers.
Dumont, G J H; Wezenberg, E; Valkenberg, M M G J; de Jong, C A J; Buitelaar, J K; van Gerven, J M A; Verkes, R J.
Afiliação
  • Dumont GJ; Unit for Clinical Psychopharmacology and Neuropsychiatry (UCPN), Department of Psychiatry, University Medical Centre St Radboud, Nijmegen, The Netherlands. G.J.H.Dumont@psy.umcn.nl
Psychopharmacology (Berl) ; 197(3): 465-74, 2008 Apr.
Article em En | MEDLINE | ID: mdl-18305926
ABSTRACT
RATIONALE In Western societies, a considerable percentage of young people expose themselves to 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"). Commonly, ecstasy is used in combination with other substances, in particular alcohol (ethanol). MDMA induces both arousing as well as hallucinogenic effects, whereas ethanol is a general central nervous system depressant.

OBJECTIVE:

The aim of the present study is to assess the acute effects of single and co-administration of MDMA and ethanol on executive, memory, psychomotor, visuomotor, visuospatial and attention function, as well as on subjective experience. MATERIALS AND

METHODS:

We performed a four-way, double-blind, randomised, crossover, placebo-controlled study in 16 healthy volunteers (nine male, seven female) between the ages of 18-29. MDMA was given orally (100 mg) and blood alcohol concentration was maintained at 0.6 per thousand by an ethanol infusion regime.

RESULTS:

Co-administration of MDMA and ethanol was well tolerated and did not show greater impairment of performance compared to the single-drug conditions. Impaired memory function was consistently observed after all drug conditions, whereas impairment of psychomotor function and attention was less consistent across drug conditions.

CONCLUSIONS:

Co-administration of MDMA and ethanol did not exacerbate the effects of either drug alone. Although the impairment of performance by all drug conditions was relatively moderate, all induced significant impairment of cognitive function.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cognição / N-Metil-3,4-Metilenodioxianfetamina / Etanol / Testes Neuropsicológicos Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Female / Humans / Male Idioma: En Revista: Psychopharmacology (Berl) Ano de publicação: 2008 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cognição / N-Metil-3,4-Metilenodioxianfetamina / Etanol / Testes Neuropsicológicos Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Female / Humans / Male Idioma: En Revista: Psychopharmacology (Berl) Ano de publicação: 2008 Tipo de documento: Article